Luis Labeaga

Preclinical Pharmacology of Bilastine,??a New Selective Histamine??H1 ??Receptor Antagonist

Reyes Corc stegui, Luis Labeaga, Ana Inner rity et al. · Drugs in R&D · 2005 · 105 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors

Gökçen Eren, Serdar Ünlü, Maria-Teresa Nuñez et al. · Bioorganic & Medicinal Chemistry · 2010 · 103 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

In Vivo Pharmacological Characterisation of Bilastine, a Potent??and Selective Histamine H1??Receptor Antagonist

Reyes Corc stegui, Luis Labeaga, Ana Inner rity et al. · Drugs in R&D · 2006 · 75 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Bilastine <i>vs.</i> hydroxyzine: occupation of brain histamine <scp>H</scp>₁‐receptors evaluated by positron emission tomography in healthy volunteers

Clara Pérez‐Mañá, Esther Papaseit, E. Menoyo et al. · British Journal of Clinical Pharmacology · 2014 · 66 citations · Full text

Medicine, Neuroscience, Pharmacology +13

New 2-Piperazinylbenzimidazole Derivatives as 5-HT₃Antagonists. Synthesis and Pharmacological Evaluation

Aurelio Orjales, Ramón Mosquera, Luis Labeaga et al. · Journal of Medicinal Chemistry · 1997 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16